Article Information
- Received June 5, 2022
- Revision received October 24, 2022
- Accepted November 19, 2022
- First published December 5, 2022.
- Version of record published January 11, 2023.
Author Information
- Yuewen Chen1,2,3,*,
- Zhenyan Xu1,*,
- Jing Chen1,2,*,
- Yue Qiu3,
- Lin Yuan3,
- Peng Liu3,
- Jing Duan4,
- Li Chen4, and
- Yu Chen1,2,3
- 1Chinese Academy of Sciences Key Laboratory of Brain Connectome and Manipulation, Shenzhen Key Laboratory of Translational Research for Brain Diseases, Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shenzhen–Hong Kong Institute of Brain Science–Shenzhen Fundamental Research Institutions, Shenzhen, 518055, China
- 2Shenzhen College of Advanced Technology, University of Chinese Academy of Sciences, Beijing, 100049, China
- 3Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen, 518057, China
- 4Department of Neurology, Shenzhen Children's Hospital, Shenzhen, 518038, China
Author contributions
Author contributions: Yuewen Chen, L.C., and Yu Chen designed research; Yuewen Chen, Z.X., J.C., Y.Q., P.L., and J.D. performed research; Yuewen Chen, Z.X., J.C., Y.Q., L.Y., J.D., L.C., and Yu Chen analyzed data; Yuewen Chen and Yu Chen wrote the paper; Z.X. wrote the first draft of the paper; L.C. and Yu Chen edited the paper.
↵*Yuewen Chen, Z.X., and J.C. contributed equally to this work.
Disclosures
- Received June 5, 2022.
- Revision received October 24, 2022.
- Accepted November 19, 2022.
This work was supported in part by the National Key R&D Program of China 2018YFE0203600 and 2021YFE0203000; National Natural Science Foundation of China/RGC Joint Research Scheme 32061160472; Guangdong Provincial Fund for Basic and Applied Basic Research 2019B1515130004 and 2019A1515011425; Guangdong Provincial Key S&T Program 2018B030336001; Shenzhen Knowledge Innovation Program JCYJ20220818100800001, JCYJ20200109115631248, and ZDSYS20200828154800001; Shenzhen Fund for Guangdong Provincial High level Clinical Key Specialties SZGSP012; and Sanming Project of Medicine in Shenzhen SZSM201812005. We thank the members of the Chen laboratory for helpful discussions.
The authors declare no competing financial interests.
- Correspondence should be addressed to Li Chen at chenli200{at}126.com or Yu Chen at yu.chen{at}siat.ac.cn
Funding
MOST | National Key Research and Development Program of China (NKPs)
2018YFE0203600; 2021YFE0203000National natural science foundation of China/RGC joint Research Scheme
32061160472Guangdong provincial key S&T program
2018B030336001Guangdong Provincial Fund for Basic and Applied Basic Research
2019B1515130004; 2019A1515011425Shenzhen Knowledge Innovation Program (深圳知识创新计划基础研究)
JCYJ20180507183642005; JCYJ20200109115631248Shenzhen Fund for Guangdong Provincial High level Clinical Key Specialties
No.SZGSP012Sanming Project of Medicine in Shenzhen
SZSM201812005
Other Version
- previous version (December 05, 2022).
- You are viewing the most recent version of this article.
Online Impact
